# ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance

> **NCT04895085** · NA · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 51 (actual)

## Conditions studied

- COVID-19
- Children With Medical Complexity (CMC)

## Interventions

- **DIAGNOSTIC_TEST:** BinaxNOW Rapid Antigen System

## Key facts

- **NCT ID:** NCT04895085
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-27
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2024-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04895085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04895085, "ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04895085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*